Cardiovascular Regeneration with Stem Cells (2026 Research)
How stem cell therapy regenerates cardiovascular tissue. Research on MSC treatments for heart failure, coronary artery disease, and cardiac tissue repair and regeneration.
MSC Therapy for Heart Disease
Cardiovascular disease remains the world's leading cause of death, largely because the heart has limited natural regenerative capacity. MSC therapy offers a new approach: promoting angiogenesis (new blood vessel formation), reducing inflammatory damage, and regenerating cardiomyocytes to restore cardiac function.
What Conditions Benefit from Cardiac MSC Therapy?
Clinical evidence supports MSC therapy for heart failure (ischemic and non-ischemic), post-myocardial infarction damage, cardiomyopathy, coronary artery disease, and angina. Studies consistently show improvements in ejection fraction, 6-minute walk test performance, and NYHA functional class after MSC treatment.
Delivery Methods
Cardiac MSC therapy typically uses intravenous infusion (for systemic anti-inflammatory effects) combined with targeted intracoronary delivery in some protocols. Our cardiac protocols include pre-treatment echocardiography, cardiology consultation, and comprehensive post-treatment cardiac monitoring.
Frequently Asked Questions
How does stem cell therapy help cardiovascular disease?
Mesenchymal stem cells (MSCs) promote angiogenesis, reduce inflammation, and regenerate damaged heart tissue. Clinical studies show improvements in ejection fraction, exercise tolerance, and overall cardiac function after MSC therapy.
What types of heart conditions can be treated with stem cells?
We treat heart failure, coronary artery disease, cardiomyopathy, and post-heart attack damage. MSC therapy helps restore blood flow, repair scarred myocardium, and improve heart pumping capacity.
How many stem cell sessions are needed for heart disease?
Most cardiovascular patients undergo 1-2 treatment sessions. Each session involves IV infusion of 30-100 million MSCs. Follow-up sessions may be recommended at 6-12 month intervals depending on response.
Is stem cell therapy for heart disease safe?
Yes. MSC therapy for cardiovascular conditions has an excellent safety profile. Our Wharton's jelly-derived stem cells are immunologically privileged, minimizing rejection risk. Over 4,850 patients treated with no serious adverse events.
What results can I expect from cardiovascular stem cell therapy?
Patients typically report improved energy, reduced shortness of breath, better exercise tolerance, and enhanced quality of life within 2-6 months. Echocardiogram improvements are often measurable within 3-6 months.
Transform Your Health with Regenerative Medicine in Istanbul
Experience the future of medicine at StemCell Longevita. Our licensed medical professionals use physician-directed regenerative medicine applications to help you pursue optimal health and longevity.
